IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
Generic: IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE
Sun Pharmaceutical IndustriesManufacturer
RESPIRATORY (INHALATION)Route
IPRATROPIUM BROMIDEActive Substance
2017-08-07Original Approval
IPRATROPIUM BROMIDE AND ALBUTEROL SULFATE is FDA application ANDA207875, sponsored by SUN PHARM. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Recalls
Class II2024-03-26
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution USP, 0.5 mg & 3mg/3mL unit-dose vials, packaged in carton Short fill: Complaints received of less fill volume in respule and few drops of liquid observed in t
Class II2015-08-21
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution, packaged in 30x3 mL Sterile Unit-Dose Vials, Lack of Assurance of Sterility; potential exposure to non-sterile lubricant during the filling proce
Class II2022-01-26
Ipratropium Bromide and Albuterol Sulfate Inhalation Solution (0.5 mg/3 mg per 3 mL), 60 x 3 mL Sterile Unit-Dose Vials CGMP Deviations: Products were exposed to temperatures outside of the products labeled storage condi
Class III2022-04-13
Ipratropium Bromide 0.5 mg and Albuterol Sulfate 3 mg Inhalation Solution 3mL vial, packaged in a) 30-count (NDC 0487-cGMP deviations: Temperature abuse
Top Reported Reactions
1
DYSPNOEA
278 reports
2
DRUG INEFFECTIVE
180 reports
3
PNEUMONIA
118 reports
4
COUGH
112 reports
5
FATIGUE
110 reports
6
NAUSEA
97 reports
7
HEADACHE
88 reports
8
DIZZINESS
83 reports
9
DEATH
81 reports
10
CHRONIC OBSTRUCTIVE PULMONARY DISEASE
72 reports